Literature DB >> 1326828

Mapping of the RD phenotype of the Nancy strain of coxsackievirus B3.

A M Lindberg1, R L Crowell, R Zell, R Kandolf, U Pettersson.   

Abstract

The RD variants of group B coxsackieviruses differ from their parental strains in having the ability to replicate in a human rhabdomyosarcoma cell line, RD. The nucleotide sequence of the P1 region of the RD variant of coxsackievirus B3 strain Nancy (CB3NRD) was determined by sequencing cloned cDNAs, obtained by PCR amplification. A comparison between the established nucleotide sequence and that of the P1 region from the parental virus revealed 12 point mutations which corresponded to six amino acid replacements. To identify if the P1 region is responsible for the phenotype of CB3NRD, a chimeric virus was constructed, using an infectious cDNA clone of CB3. The P1 region of the infectious cDNA was replaced by cDNA fragments from CB3N (parental strain Nancy) or CB3NRD and the resulting recombinants were assayed for their ability to infect and replicate in RD cells. The results showed that the RD phenotype of CB3NRD maps in the P1 region. Furthermore, a chimera which only contained the 5' part of the P1 region derived from CB3NRD and the remaining P1 sequence from CB3N was able to replicate in RD cells, suggesting that the VP2 polypeptide contains at least one determinant for the RD phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1326828     DOI: 10.1016/0168-1702(92)90006-u

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  21 in total

1.  Structure of decay-accelerating factor bound to echovirus 7: a virus-receptor complex.

Authors:  Yongning He; Feng Lin; Paul R Chipman; Carol M Bator; Timothy S Baker; Menachem Shoham; Richard J Kuhn; M Edward Medof; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

2.  Complement component 3 interactions with coxsackievirus B3 capsid proteins: innate immunity and the rapid formation of splenic antiviral germinal centers.

Authors:  D R Anderson; C M Carthy; J E Wilson; D Yang; D V Devine; B M McManus
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.

Authors:  Aaron M Milstone; JenniElizabeth Petrella; Melissa D Sanchez; Mariam Mahmud; J Charles Whitbeck; Jeffrey M Bergelson
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 4.  Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis.

Authors:  P Muir; U Kämmerer; K Korn; M N Mulders; T Pöyry; B Weissbrich; R Kandolf; G M Cleator; A M van Loon
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

5.  Single amino acid changes in the virus capsid permit coxsackievirus B3 to bind decay-accelerating factor.

Authors:  Jieyan Pan; Bhargavi Narayanan; Shardule Shah; Joshua D Yoder; Javier O Cifuente; Susan Hafenstein; Jeffrey M Bergelson
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

6.  Determinants of the recognition of enteroviral cloverleaf RNA by coxsackievirus B3 proteinase 3C.

Authors:  Roland Zell; Karim Sidigi; Enrico Bucci; Axel Stelzner; Matthias Görlach
Journal:  RNA       Date:  2002-02       Impact factor: 4.942

7.  A decay-accelerating factor-binding strain of coxsackievirus B3 requires the coxsackievirus-adenovirus receptor protein to mediate lytic infection of rhabdomyosarcoma cells.

Authors:  D R Shafren; D T Williams; R D Barry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.

Authors:  Roland Zell; René Markgraf; Michaela Schmidtke; Matthias Görlach; Axel Stelzner; Andreas Henke; Holger H Sigusch; Brigitte Glück
Journal:  Med Microbiol Immunol       Date:  2003-09-26       Impact factor: 3.402

9.  Slow Infection due to Lowering the Amount of Intact versus Empty Particles Is a Characteristic Feature of Coxsackievirus B5 Dictated by the Structural Proteins.

Authors:  Paula Turkki; Mira Laajala; Marie Stark; Helena Vandesande; Heidi Sallinen-Dal Maso; Sailee Shroff; Anna Sävneby; Ganna Galitska; A Michael Lindberg; Varpu Marjomäki
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

10.  Interaction of decay-accelerating factor with coxsackievirus B3.

Authors:  Susan Hafenstein; Valorie D Bowman; Paul R Chipman; Carol M Bator Kelly; Feng Lin; M Edward Medof; Michael G Rossmann
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.